Edge Capital Group, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
Edge Capital Group, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$328,349
+10.1%
3,0840.0%0.02%
+6.7%
Q1 2024$298,340
+2.7%
3,084
+7.2%
0.02%
-6.2%
Q4 2023$290,440
-0.9%
2,8770.0%0.02%
-15.8%
Q3 2023$293,000
-5.0%
2,877
-5.9%
0.02%
+5.6%
Q2 2023$308,457
+9.7%
3,0570.0%0.02%
+5.9%
Q1 2023$281,221
-1.3%
3,057
-2.7%
0.02%
-15.0%
Q4 2022$284,929
+22.8%
3,141
+2.7%
0.02%
+5.3%
Q3 2022$232,000
-12.5%
3,057
-2.5%
0.02%
-17.4%
Q2 2022$265,000
-21.8%
3,134
-18.9%
0.02%0.0%
Q1 2022$339,000
+23.7%
3,865
+23.2%
0.02%
+21.1%
Q4 2021$274,000
+6.6%
3,137
-0.0%
0.02%
-5.0%
Q3 2021$257,000
-12.9%
3,138
-3.1%
0.02%
-16.7%
Q2 2021$295,000
-18.3%
3,238
-23.2%
0.02%
-20.0%
Q1 2021$361,000
-95.1%
4,218
-94.5%
0.03%
-95.1%
Q4 2020$7,300,000
-7.5%
77,310
-14.8%
0.62%
-22.0%
Q3 2020$7,890,000
+52.8%
90,726
+53.5%
0.79%
+45.9%
Q2 2020$5,163,000
-24.2%
59,113
-28.5%
0.54%
-33.6%
Q1 2020$6,812,000
-28.0%
82,625
-17.3%
0.81%
-11.6%
Q4 2019$9,461,000
-4.9%
99,912
-12.7%
0.92%
-8.5%
Q3 2019$9,946,000
-7.6%
114,451
-3.0%
1.01%
-2.8%
Q2 2019$10,769,000
+6.6%
117,940
+12.2%
1.04%
+4.0%
Q1 2019$10,103,000
+9.4%
105,083
-2.3%
1.00%
-0.7%
Q4 2018$9,232,000107,5891.00%
Other shareholders
NOVARTIS A G shareholders Q4 2018
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders